Somatostatin Analogs Market to Reach USD 15.01 Billion by 2032 Market Overview
The Somatostatin Analogs Market is entering a period of sustained expansion as demand for targeted therapies for hormonal disorders and neuroendocrine diseases increases worldwide. Growing research and development activity, rising diagnosis of Neuroendocrine Tumors (NETs), and increasing awareness of conditions such as acromegaly are creating new opportunities for...
0 Megosztás
157 Nézettség